• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. A Comparative Assessment of Safety, Efficacy And Cost Effectiveness Of Glipizide-Metformin And Glimepiride-Metformin Combination Therapy In Type-2 Diabetes Mellitus

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

A Comparative Assessment of Safety, Efficacy And Cost Effectiveness Of Glipizide-Metformin And Glimepiride-Metformin Combination Therapy In Type-2 Diabetes Mellitus

    Author

    • Mina Shahraki Mohammadi , Manouchehr Khanipour
,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

Diabetes mellitus (DM) is defined as a chronic and metabolic disorder. It was approximated about 77 million Indians suffer from DM and it will be increased to 134 million by 2045. Diabetic mellitus can be treated by close control of glucose level which is main aim and target in management of this condition. Management of DM can be done by non-pharmacological and pharmacological approaches. The aim of this study is to compare the safety, efficacy and cost effectiveness of Glipizide-Metformin and Glimepiride-Metformin combination therapy in type 2 diabetes mellitus. In current research by use of prospective method in the cardiology department of Kongunad Multi-speciality Hospital, Coimbatore, in a period of six months from February 2021 to August 2021 we did research according to our aim and used ANOVA statistical test whenever it needed. Our study results demonstrate, the improvement in the addition of glimipride 2mg to metformin 500 mg has modest beneficial then glipizide 5 mg in terms of efficacy and cost. In terms of safety, both drugs are having similar safety profiles. Current research also assessed the medication safety by using the Naranjo scale

Keywords

  • diabetes mellitus
  • anti-diabetic medication
  • Hyperglycemia
  • medication safety
  • XML
  • PDF 330.88 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 78
    • PDF Download: 135
European Journal of Molecular & Clinical Medicine
Volume 9, Issue 7
September 2022
Page 9348-9353
Files
  • XML
  • PDF 330.88 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 78
  • PDF Download: 135

APA

Manouchehr Khanipour, M. S. M. ,. (2023). A Comparative Assessment of Safety, Efficacy And Cost Effectiveness Of Glipizide-Metformin And Glimepiride-Metformin Combination Therapy In Type-2 Diabetes Mellitus. European Journal of Molecular & Clinical Medicine, 9(7), 9348-9353.

MLA

Mina Shahraki Mohammadi , Manouchehr Khanipour. "A Comparative Assessment of Safety, Efficacy And Cost Effectiveness Of Glipizide-Metformin And Glimepiride-Metformin Combination Therapy In Type-2 Diabetes Mellitus". European Journal of Molecular & Clinical Medicine, 9, 7, 2023, 9348-9353.

HARVARD

Manouchehr Khanipour, M. S. M. ,. (2023). 'A Comparative Assessment of Safety, Efficacy And Cost Effectiveness Of Glipizide-Metformin And Glimepiride-Metformin Combination Therapy In Type-2 Diabetes Mellitus', European Journal of Molecular & Clinical Medicine, 9(7), pp. 9348-9353.

VANCOUVER

Manouchehr Khanipour, M. S. M. ,. A Comparative Assessment of Safety, Efficacy And Cost Effectiveness Of Glipizide-Metformin And Glimepiride-Metformin Combination Therapy In Type-2 Diabetes Mellitus. European Journal of Molecular & Clinical Medicine, 2023; 9(7): 9348-9353.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus